Neuroprotective trial design methodology for Parkinson’s: a scoping review
Objective: To further understanding of the diversity and impact of trial design choices in trials of disease modifying therapy (DMT) in Parkinson’s disease (PD). Background:…The Achilles’ heel of a craftsman, a complication of Guillain-Barré Syndrome
Objective: To report the case of a patient developing tremor in the course of Guillain-Barré Syndrome (GBS) Background: Neuropathic tremor is a movement disorder that…Incidental Lewy Body disease and idiopathic Parkinson’s disease: from common pathogenic factors to the overlapping clinical features
Objective: To compare established early symptoms and risk factors associated with Parkinson’s disease (PD) in a cohort of incidental Lewy Body disease (iLBD) and healthy…COVID-19 impact on Anxiety, Depression, Stress, and Cortisol in Persons with Parkinson’s Disease
Objective: To assess psychological stress, through subjective and objective measures, in Parkinson’s disease (PD) prior to and during the worldwide pandemic. Background: We have had…Striatal Subregion Analysis Associated with REM Sleep Behavior Disorder in Parkinson’s disease
Objective: Herein we evaluated the regional selectivity of presynaptic striatal dopaminergic denervation associated with RBD in drug-naive early PD. Background: REM sleep behavior disorder (RBD)…Association between sleep apnea and prognosis in patients with multiple system atrophy
Objective: We aimed to investigate the relationship between sleep apnea and survival or early frequent falls in patients with multiple system atrophy (MSA). Background: Sleep-disordered…Painful arm spasms after remote electrical injury: focal epilepsy begets causalgia-dystonia?
Objective: We describe a case of episodic, painful arm spasms with involuntary tremulous movements, after remote electrocution injury. Background: A variety of movement disorders have…Availability and accessibility of medicines for patients with Parkinson’s disease in Kyrgyzstan
Objective: The aim of the study was to assess the availability and accessibility of medicines for patients with Parkinson’s disease (PD) in Kyrgyzstan. Background: After…IncobotulinumtoxinA for treating chronic sialorrhea due to Parkinson’s disease and other neurological conditions
Objective: To summarize clinical experience with incobotulinumtoxinA (INCO) for treating chronic sialorrhea due to Parkinson’s disease (PD), atypical parkinsonism, stroke, or traumatic brain injury in…CLINICAL CHARACTERSITICS OF ESSENTIAL TREMOR PATIENTS THAT DEVELOPE PARKINSON´S DISEASE: A COHORT BASED STUDY.
Objective: To elucidate the clinical characteristics of those patients previously diagnosed with essential tremor ( ET ) that finally developed a Parkinson´s disease during the follow…
- « Previous Page
- 1
- …
- 122
- 123
- 124
- 125
- 126
- …
- 153
- Next Page »